Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal
Overall survival rates of 200 patients with non-Hodgkin lymphoma by the... | Download Scientific Diagram
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
Progression-free survival (PFS) in low-grade non-Hodgkin lymphomas (a;... | Download Scientific Diagram
Life expectancy of young adults with follicular lymphoma - ScienceDirect
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
![PDF] Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a2b4dcdec1ba817c0d692597b011651461cbf72e/6-Figure2-1.png "PDF] Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence. | Semantic Scholar")
PDF] Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence. | Semantic Scholar
Overall survival (OS) of patients with follicular lymphoma who had... | Download Scientific Diagram
Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma | Signal Transduction and Targeted Therapy
Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
Estimating Long-Term Survival for Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy: A Comparison of Standard and Mixture Cure Models - Biology of Blood
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma | NEJM
Mantle Cell Lymphoma: Treatment Overview - CancerConnect
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis | BMC Cancer | Full Text
Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... | Download Scientific Diagram
Overall survival according to biologic Mantle-Cell Lymphoma (MCL)... | Download Scientific Diagram
Epidemiologic characteristics, treatment patterns, and survival analysis of Plasmablastic Lymphoma in the US: A SEER and NCDB analysis. - ScienceDirect
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley Online Library
Overall survival of patients with non-Hodgkin's lymphoma receiving... | Download Scientific Diagram
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma | NEJM
World J Oncol
Lymphoma prognosis: Survival rates for Hodgkin and non-Hodgkin
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
